Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Sep 30, 2022
TickeronGET DAILY SIGNALS
Bed Bath & Beyond (BBBY, $6.19) posts wider-than-expected loss

Bed Bath & Beyond (BBBY, $6.19) posts wider-than-expected loss

Bed Bath & Beyond posted a adjusted loss per share of -$3.22 for the three months ending August, wider than the -$1.85 expected by analysts' polled by Refinitiv.

Revenue came in  $1.44 billion, plunging -28% from the year-ago quarter.  The figure also missed analysts’ estimate of $1.47 billion.

According to Interim CEO Sue Gove’s statement in a news release, the home goods retail company’s quarterly results do not reflect its recent weeks’ progress. She said the company is resolving inventory issues by speeding up markdowns of some merchandise. Bed Bath is “confident that our current liquidity will enable the necessary changes we are implementing,” Gove said.

Gove said the company’s loyalty program, Welcome Rewards, has expanded by more than 1.3 million since the end of August, leading to a total of 6.4 million members. She said it is cutting costs by about $250 million for the second half of the fiscal year, while intending to boost sales.

Related Ticker: BBBY

Contributor

Sergey Savastiouk's AvatarSergey Savastiouk|Expert

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.

View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
View AI-Driven Trading for BBBY
A.I. Advisor
published General Information

General Information

Industry InternetRetail

Interact to see
Advertisement

U-BX Technology Ltd. (UBXG): +79% Surge in 30 Days Signals Insurtech Momentum

UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
UBXG#AdvertisingMarketingServices
Joma Foster, expert
Apr 02, 2026

Why Commercial Vehicle Group (CVGI) Stock Surged +89% in the Last 30 Days

CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
CVGI#AutoPartsOEM
Joma Foster, expert
Apr 02, 2026

XCF Global (SAFX): +104% Surge in 30 Days Amid Capital Raise and Merger Momentum

SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
SAFT#PropertyCasualtyInsurance
Joma Foster, expert
Apr 02, 2026

LeonaBio (LONA): +80% Surge in 30 Days on Pipeline Momentum and Analyst Upgrades

LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
LONA#Biotechnology
Joma Foster, expert
Apr 02, 2026

Lifetime Brands (LCUT): +77% Surge in 30 Days on Earnings Strength and Strong Buy Rating

Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
LCUT#HomeFurnishings
Joma Foster, expert
Apr 01, 2026

Torrid Holdings (CURV): +73% Surge in 30 Days Amid Earnings Beat and Store Optimizations

CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
CURV#ApparelFootwearRetail
Joma Foster, expert
Apr 02, 2026

Blaize Holdings (BZAI): +72% Surge in 30 Days Amid Earnings Strength and AI Edge Momentum

Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
BZAI#PackagedSoftware
Joma Foster, expert
Apr 02, 2026

Comstock Holding Companies (CHCI): +65% Surge in 30 Days on Strong Earnings and Expansion

Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
CHCI#RealEstateDevelopment
Joma Foster, expert
Apr 02, 2026

GE Aerospace (GE) Stock Drops -12% in 30 Days: What's Behind the Pullback?

GE Aerospace (GE) stock declined -12% over the past 30 days, falling from around $333 to $293, amid profit-taking after record highs near $348. Over the past quarter, the stock is down -8%, reflecting post-earnings selloff despite strong Q4 2025 results with 20% revenue growth.
GE#AerospaceDefense
Alicia, beginner
Apr 01, 2026

Arm Holdings (ARM): +26% Surge in 30 Days on AI Chip Momentum and Analyst Upgrades

ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
ARM#Semiconductors
Alicia, beginner
Apr 02, 2026

Sable Offshore Corp. (SOC): +92% Surge in 30 Days on Pipeline Restart and Analyst Upgrades

Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
SOC#ContractDrilling
Alicia, beginner
Apr 03, 2026

Nabors Industries (NBR): +12% in 30 Days and +58% Quarterly Surge

NBR stock rose approximately +12% over the last 30 days, driven by positive momentum in the oil and gas drilling sector and strong Q4 earnings beat. Over the past quarter, the stock surged +58%, fueled by robust YTD performance, debt reduction efforts, and improved operational results in international drilling.
NBR#ContractDrilling
Alicia, beginner
Apr 01, 2026

Patterson-UTI Energy (PTEN): +23% in 30 Days Amid Earnings Strength and Sector Tailwinds

Patterson-UTI Energy, Inc. (PTEN) stands out as a leading provider of drilling and completion services to oil and natural gas exploration and production companies, primarily in the United States and select international markets. The company operates through three main segments: Drilling Services, which includes contract drilling rigs and directional drilling; Completion Services, encompassing hydraulic fracturing, wireline, and pumping; and Drilling Products, offering specialized drill bits globally, including in the Middle East.
PTEN#ContractDrilling
Alicia, beginner
Apr 01, 2026

Patterson-UTI Energy (PTEN): What to Expect from the Q1 2026 Earnings Report

As a provider of onshore drilling and completion services, Patterson-UTI Energy (PTEN) is gearing up for a key Q1 2026 earnings report against the backdrop of fluctuating oil prices and steady U.S. rig demand. The company's integrated approach across Drilling Services, Completion Services, and Drilling Products gives it a solid footing in North American shale plays. In my view, recent quarters like Q4 2025, where revenue exceeded estimates despite a net loss, highlight its resilience. This upcoming report will offer insights into activity levels, margin trends, and capital discipline amid supply growth and geopolitical tensions. With strong free cash flow and recent dividend increases, PTEN's focus on shareholders stands out, making this a critical gauge for the 2026 outlook in the cyclical oilfield services sector.
PTEN#ContractDrilling
Alicia, beginner
Apr 01, 2026

76% Win Rate, +76.22% Return: How AI Trades Oil & Energy Stocks During Geopolitical Crisis

When geopolitical turmoil sends markets into chaos, most retail traders freeze — but Tickeron's Energy (OXY, EOG, DVN, FANG, APA, MTDR) AI Trading Agent is built to thrive in exactly these conditions. This 15-minute and 60-minute AI-powered robot has delivered a +76.22% annualized return with a 64.21% win rate and a Profit Factor of 2.70 — trading six of the most volatile and opportunity-rich energy tickers on the market.
OXYEOGFANG#OilGasProduction
Apr 01, 2026

+49% Annualized Return: How to Trade Oil & Gas Stocks During War, Sanctions & Energy Shocks with Tickeron's AI Robot

The global energy sector is on fire — literally and figuratively. With crude oil prices swinging 20–30% in response to geopolitical flashpoints, OPEC+ production cuts, and escalating conflicts in Eastern Europe and the Middle East, traders who aren't using AI-powered tools are flying blind. Enter Tickeron's Energy (Oil & Gas – E&P) AI Trading Agent — a 60-minute signal robot built exclusively around five high-impact Exploration & Production tickers, now posting a staggering +49% Annualized Return and +1,251% 30-Day Annualized Return, with $14,703 in closed-trade P&L on a $30,000 simulated balance.
DVNOVVSM#OilGasProduction
Apr 01, 2026

Cheniere Energy Partners (CQP): Navigating LNG Expansion Amid Valuation Caution

From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
CQP#OilGasPipelines
Apr 01, 2026

Regeneron Pharmaceuticals (REGN): Pipeline Catalysts and Growth Drivers in a Competitive Biotech Landscape

In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
REGN#Biotechnology
Apr 01, 2026

argenx SE (ARGX): Strong Buy Consensus Signals +30% Upside Amid 2026 Catalysts

As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
ARGX#Biotechnology
Apr 01, 2026

Alnylam Pharmaceuticals (ALNY): Strong TTR Growth and Pipeline Catalysts Ahead

I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
ALNY#Biotechnology
Apr 01, 2026
Bed Bath & Beyond (BBBY, $6.19) posts wider-than-expected loss